
Vopril M 2mg/500mg Tablet SR
Marketer
Voopar Sciences Pvt Ltd
Salt Composition
Glimepiride (2mg) + Metformin (500mg)
Overview Vopril M 2mg/500mg Tablet SR
DiabetaComb 2mg/500mg Extended-Release Tablets are classified as antidiabetic medications. This dual-action formulation treats type 2 diabetes in adults by managing blood glucose levels. DiabetaComb 2mg/500mg ER Tablets are administered with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continued use is crucial, even with controlled blood sugar, as discontinuation without medical supervision risks elevated glucose levels and potential complications such as nephropathy, retinopathy, neuropathy, and limb loss. This medication complements a comprehensive diabetes management plan involving diet, exercise, and weight management as directed by your doctor. Lifestyle adjustments significantly impact diabetes control. Hypoglycemia (low blood sugar) is the most frequent adverse effect, characterized by sweating, lightheadedness, headache, and tremors. Regular meals and readily available glucose sources (e.g., sugary snacks or juice) are essential for prevention. Alcohol consumption should be limited due to its potential to exacerbate hypoglycemia. Additional possible side effects include altered taste perception, nausea, diarrhea, abdominal discomfort, cephalalgia, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Prior heart conditions should be disclosed to your physician before initiating treatment. Pregnant or lactating individuals require medical consultation before use. Regular blood glucose monitoring and periodic blood tests to assess blood cell counts and liver function are recommended.
Primary Ingredients of Vopril M 2mg/500mg Tablet SR
No text provided. Please provide the text you wish me to rephrase.
Uses of Vopril M 2mg/500mg Tablet SR
Managing Type 2 diabetes
Major Benefits of Vopril M 2mg/500mg Tablet SR:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Vopril M 2mg/500mg Extended-Release tablets with a meal.
Common Side effects of Vopril M 2mg/500mg Tablet SR:
- Headache
- Hypoglycemia (low blood glucose level)
- Nausea
- Diarrhea
How to use Vopril M 2mg/500mg Tablet SR:
Consume this medication precisely as your physician directs, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The Vopril M 2mg/500mg sustained-release tablet should be taken with a meal.
How Vopril M 2mg/500mg Tablet SR works:
Vopril M SR tablets (2mg/500mg) combine glimepiride and metformin to manage blood sugar. Glimepiride, a sulfonylurea, stimulates the pancreas to release more insulin, thus reducing blood glucose levels. Metformin, a biguanide, acts through multiple mechanisms: decreasing hepatic glucose production, slowing intestinal glucose uptake, and enhancing insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Combining Vopril M 2mg/500mg SR tablets with alcohol is hazardous.
PregnancyCONSULT YOUR DOCTOR
Extended-release Vopril M tablets (2mg/500mg) may pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.
Breast feedingUNSAFE
Extended-release Vopril M tablets (2mg/500mg) are contraindicated for breastfeeding mothers due to potential infant toxicity.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if these conditions arise.
KidneyCAUTION
Individuals with impaired kidney function should use Vopril M 2mg/500mg SR tablets cautiously, potentially requiring dosage modification. Consult your physician for guidance. Vopril M 2mg/500mg SR tablets are contraindicated in patients with severely compromised kidney function. Routine monitoring of kidney function is recommended during treatment.
LiverCAUTION
Patients with liver impairment should use Vopril M 2mg/500mg SR tablets cautiously, potentially requiring dosage modification. Consult a physician. For those with mild to moderate liver disease, a low initial dose is typical; however, Vopril M 2mg/500mg SR tablets are unsuitable for individuals with severe hepatic dysfunction.
What if you forget to take Vopril M 2mg/500mg Tablet SR :
Should you forget to take a Vopril M 2mg/500mg sustained-release tablet, administer it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Vopril M 2mg/500mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
